골육종 (Korean Wikipedia)

Luetke A, Meyers PA, Lewis A, Juergens H (2014). “Osteosarcoma treatment—where do we stand? A state of the art review”. 《Cancer Treat Rev》 40 (4): 523–532. doi:10.1016/j.ctrv.2013.11.006. PMID 24345772.
Ottaviani G, Jaffe N (2009). 〈The Epidemiology of Osteosarcoma〉. 《Pediatric and Adolescent Osteosarcoma》. Cancer Treatment and Research 152. New York: Springer. 3–13쪽. doi:10.1007/978-1-4419-0284-9_1. ISBN 978-1-4419-0283-2. PMID 20213383.
Osuna D, de Alava E (2009). “Molecular pathology of sarcomas”. 《Rev Recent Clin Trials》 4 (1): 12–26. doi:10.2174/157488709787047585. hdl:10261/61716. PMID 19149759. S2CID 15039305.
Sharma, Ankush; Cinti, Caterina; Capobianco, Enrico (2017). “Multitype Network-Guided Target Controllability in Phenotypically Characterized Osteosarcoma: Role of Tumor Microenvironment” (영어). 《Frontiers in Immunology》 8: 918. doi:10.3389/fimmu.2017.00918. ISSN 1664-3224. PMC 5536125. PMID 28824643.
Sharma, Ankush; Capobianco, Enrico (2017). “Immuno-Oncology Integrative Networks: Elucidating the Influences of Osteosarcoma Phenotypes” (영어). 《Cancer Informatics》 16: 117693511772169. doi:10.1177/1176935117721691. ISSN 1176-9351. PMC 5533255. PMID 28804242.
Dhaliwal J, Sumathi VP, Grimer RJ (2009년 12월 20일). “Radiation-induced periosteal osteosarcoma” (PDF). 《Grand Rounds》 10: 13–18. doi:10.1102/1470-5206.2010.0003 (년 이후로 접속 불가 2023-08-01).
Bielack SS, Hecker-Nolting S, Blattmann C, Kager L (2016). “Advances in the management of osteosarcoma”. 《F1000Research》 5: 2767. doi:10.12688/f1000research.9465.1. PMC 5130082. PMID 27990273.
He X, Pang Z, Zhang X, Lan T, Chen H, Chen M, Yang H, Huang J, Chen Y, Zhang Z, Jing W, Peng R, Zhang H (September 2018). “Consistent Amplification of FRS2 and MDM2 in Low-grade Osteosarcoma: A Genetic Study of 22 Cases With Clinicopathologic Analysis”. 《The American Journal of Surgical Pathology》 42 (9): 1143–1155. doi:10.1097/PAS.0000000000001125. PMID 30001240. S2CID 51618887.
Blakey K, Feltbower RG, Parslow RC, James PW, Gómez Pozo B, Stiller C, Vincent TJ, Norman P, McKinney PA, Murphy MF, Craft AW, McNally RJ (2014년 1월 14일). “Is fluoride a risk factor for bone cancer? Small area analysis of osteosarcoma and Ewing sarcoma diagnosed among 0-49-year-olds in Great Britain, 1980-2005”. 《International Journal of Epidemiology》 43 (1): 224–234. doi:10.1093/ije/dyt259. PMC 3937980. PMID 24425828.
Mahoney MC, Nasca PC, Burnett WS, Melius JM (April 1991). “Bone cancer incidence rates in New York State: time trends and fluoridated drinking water”. 《American Journal of Public Health》 81 (4): 475–9. doi:10.2105/AJPH.81.4.475. PMC 1405037. PMID 2003628.
Kim FM, Hayes C, Williams PL, Whitford GM, Joshipura KJ, Hoover RN, Douglass CW, National Osteosarcoma Etiology Group (October 2011). “An assessment of bone fluoride and osteosarcoma”. 《Journal of Dental Research》 90 (10): 1171–6. doi:10.1177/0022034511418828. PMC 3173011. PMID 21799046.
Gelberg KH, Fitzgerald EF, Hwang SA, Dubrow R (December 1995). “Fluoride exposure and childhood osteosarcoma: a case-control study”. 《American Journal of Public Health》 85 (12): 1678–83. doi:10.2105/AJPH.85.12.1678. PMC 1615731. PMID 7503344.
Papalas JA, Balmer NN, Wallace C, Sangüeza OP (June 2009). “Ossifying dermatofibroma with osteoclast-like giant cells: report of a case and literature review”. 《Am J Dermatopathol》 31 (4): 379–83. doi:10.1097/DAD.0b013e3181966747. PMID 19461244.
Kundu ZS (May 2014). “Classification, imaging, biopsy and staging of osteosarcoma”. 《Indian Journal of Orthopaedics》 48 (3): 238–46. doi:10.4103/0019-5413.132491. PMC 4052020. PMID 24932027.
Ottaviani G, Jaffe N (2009). 〈The Epidemiology of Osteosarcoma〉. 《Pediatric and Adolescent Osteosarcoma》. Cancer Treatment and Research 152. New York: Springer. 3–13쪽. doi:10.1007/978-1-4419-0284-9_1. ISBN 978-1-4419-0283-2. PMID 20213383.
Wilkins RM, Cullen JW, Odom L, Jamroz BA, Cullen PM, Fink K, Peck SD, Stevens SL, Kelly CM, Camozzi AB (June 2003). “Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity”. 《Annals of Surgical Oncology》 10 (5): 498–507. doi:10.1245/ASO.2003.03.061. PMID 12794015. S2CID 32721347.
Sharma, Ankush; Cinti, Caterina; Capobianco, Enrico (2017). “Multitype Network-Guided Target Controllability in Phenotypically Characterized Osteosarcoma: Role of Tumor Microenvironment” (영어). 《Frontiers in Immunology》 8: 918. doi:10.3389/fimmu.2017.00918. ISSN 1664-3224. PMC 5536125. PMID 28824643.
Bech-Nielsen; S.; Haskins; M. E. 외 (1978). “Frequency of osteosarcoma among first-degree relatives of St. Bernard dogs”. 《J Natl Cancer Inst》 60 (2): 349–53. doi:10.1093/jnci/60.2.349. PMID 271748.
Ru, B.; Terracini, G. 외 (1998). “Host related risk factors for canine osteosarcoma”. 《Vet J》 156 (1): 31–9. doi:10.1016/S1090-0233(98)80059-2. PMID 9691849.
Ranen E, Lavy E, Aizenberg I, Perl S, Harrus S (2004). “Spirocercosis-associated esophageal sarcomas in dogs. A retrospective study of 17 cases (1997-2003)”. 《Veterinary Parasitology》 119 (2–3): 209–221. doi:10.1016/j.vetpar.2003.10.023. PMID 14746980.
Loukopoulos P, Thornton JR, Robinson WF (May 2003). “Clinical and pathologic relevance of p53 index in canine osseous tumors”. 《Veterinary Pathology》 40 (3): 237–48. doi:10.1354/vp.40-3-237. PMID 12724563.
Psychas, V; Loukopoulos, P; Polizopoulou, ZS; Sofianidis, G (March 2009). “Multilobular tumour of the caudal cranium causing severe cerebral and cerebellar compression in a dog.”. 《Journal of Veterinary Science》 10 (1): 81–3. doi:10.4142/jvs.2009.10.1.81. PMC 2801101. PMID 19255529.
Tomlin JL, Sturgeon C, Pead MJ, Muir P (2000년 7월 29일). “Use of the bisphosphonate drug alendronate for palliative management of osteosarcoma in two dogs”. 《The Veterinary Record》 147 (5): 129–32. doi:10.1136/vr.147.5.129. PMID 10958534. S2CID 35757270.
Fenger, Joelle M.; London, Cheryl A.; Kisseberth, William C. (2014). “Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology”. 《ILAR Journal》 55 (1): 69–85. doi:10.1093/ilar/ilu009. ISSN 1930-6180. PMID 24936031.
Sakthikumar, Sharadha; Elvers, Ingegerd; Kim, Jaegil; Arendt, Maja L.; Thomas, Rachael; Turner-Maier, Jason; Swofford, Ross; Johnson, Jeremy; Schumacher, Steven E.; Alföldi, Jessica; Axelsson, Erik; Couto, C. Guillermo; Kisseberth, William C.; Pettersson, Mats E.; Getz, Gad (2018년 7월 1일). “SETD2 Is Recurrently Mutated in Whole-Exome Sequenced Canine Osteosarcoma”. 《Cancer Research》 78 (13): 3421–3431. doi:10.1158/0008-5472.can-17-3558. ISSN 0008-5472. PMID 29724721.

doi.org

Sakthikumar, Sharadha; Elvers, Ingegerd; Kim, Jaegil; Arendt, Maja L.; Thomas, Rachael; Turner-Maier, Jason; Swofford, Ross; Johnson, Jeremy; Schumacher, Steven E.; Alföldi, Jessica; Axelsson, Erik; Couto, C. Guillermo; Kisseberth, William C.; Pettersson, Mats E.; Getz, Gad (2018년 7월 1일). “SETD2 Is Recurrently Mutated in Whole-Exome Sequenced Canine Osteosarcoma”. 《Cancer Research》 78 (13): 3421–3431. doi:10.1158/0008-5472.can-17-3558. ISSN 0008-5472. PMID 29724721.

epa.gov (Global: 882^nd place; Korean: 710^th place)

water.epa.gov

"Basic Information about Fluoride in Drinking Water" 보관됨 2014-12-04 - 웨이백 머신, United States Environmental Protection Agency.

grandroundsjournal.com (Global: low place; Korean: low place)

Dhaliwal J, Sumathi VP, Grimer RJ (2009년 12월 20일). “Radiation-induced periosteal osteosarcoma” (PDF). 《Grand Rounds》 10: 13–18. doi:10.1102/1470-5206.2010.0003 (년 이후로 접속 불가 2023-08-01).

handle.net (Global: 102^nd place; Korean: 307^th place)

hdl.handle.net

Osuna D, de Alava E (2009). “Molecular pathology of sarcomas”. 《Rev Recent Clin Trials》 4 (1): 12–26. doi:10.2174/157488709787047585. hdl:10261/61716. PMID 19149759. S2CID 15039305.

ivis.org (Global: low place; Korean: low place)

Withrow, S.J. (2003). “Limb Sparing Trials and Canine Osteosarcoma”. 《Genes, Dogs and Cancer: 3rd Annual Canine Cancer Conference, 2003》. 2005년 3월 15일에 원본 문서에서 보존된 문서. 2006년 6월 16일에 확인함.

lecturio.com (Global: 5,619^th place; Korean: 9,269^th place)

“Osteosarcoma”. 《The Lecturio Medical Concept Library》. 2021년 8월 25일에 확인함.

nhmrc.gov.au (Global: low place; Korean: 8,116^th place)

National Health and Medical Research Council (Australia) (2007). 《A systematic review of the efficacy and safety of fluoridation》 (PDF). ISBN 978-1-86496-415-8. 2009년 10월 14일에 원본 문서 (PDF)에서 보존된 문서. 2009년 10월 13일에 확인함.

nih.gov (Global: 4^th place; Korean: 4^th place)

ncbi.nlm.nih.gov

Luetke A, Meyers PA, Lewis A, Juergens H (2014). “Osteosarcoma treatment—where do we stand? A state of the art review”. 《Cancer Treat Rev》 40 (4): 523–532. doi:10.1016/j.ctrv.2013.11.006. PMID 24345772.
Ottaviani G, Jaffe N (2009). 〈The Epidemiology of Osteosarcoma〉. 《Pediatric and Adolescent Osteosarcoma》. Cancer Treatment and Research 152. New York: Springer. 3–13쪽. doi:10.1007/978-1-4419-0284-9_1. ISBN 978-1-4419-0283-2. PMID 20213383.
“Osteosarcoma”. 《US National Library of Medicine》. PubMed Health. 2013.
Osuna D, de Alava E (2009). “Molecular pathology of sarcomas”. 《Rev Recent Clin Trials》 4 (1): 12–26. doi:10.2174/157488709787047585. hdl:10261/61716. PMID 19149759. S2CID 15039305.
Sharma, Ankush; Cinti, Caterina; Capobianco, Enrico (2017). “Multitype Network-Guided Target Controllability in Phenotypically Characterized Osteosarcoma: Role of Tumor Microenvironment” (영어). 《Frontiers in Immunology》 8: 918. doi:10.3389/fimmu.2017.00918. ISSN 1664-3224. PMC 5536125. PMID 28824643.
Sharma, Ankush; Capobianco, Enrico (2017). “Immuno-Oncology Integrative Networks: Elucidating the Influences of Osteosarcoma Phenotypes” (영어). 《Cancer Informatics》 16: 117693511772169. doi:10.1177/1176935117721691. ISSN 1176-9351. PMC 5533255. PMID 28804242.
Bielack SS, Hecker-Nolting S, Blattmann C, Kager L (2016). “Advances in the management of osteosarcoma”. 《F1000Research》 5: 2767. doi:10.12688/f1000research.9465.1. PMC 5130082. PMID 27990273.
He X, Pang Z, Zhang X, Lan T, Chen H, Chen M, Yang H, Huang J, Chen Y, Zhang Z, Jing W, Peng R, Zhang H (September 2018). “Consistent Amplification of FRS2 and MDM2 in Low-grade Osteosarcoma: A Genetic Study of 22 Cases With Clinicopathologic Analysis”. 《The American Journal of Surgical Pathology》 42 (9): 1143–1155. doi:10.1097/PAS.0000000000001125. PMID 30001240. S2CID 51618887.
Blakey K, Feltbower RG, Parslow RC, James PW, Gómez Pozo B, Stiller C, Vincent TJ, Norman P, McKinney PA, Murphy MF, Craft AW, McNally RJ (2014년 1월 14일). “Is fluoride a risk factor for bone cancer? Small area analysis of osteosarcoma and Ewing sarcoma diagnosed among 0-49-year-olds in Great Britain, 1980-2005”. 《International Journal of Epidemiology》 43 (1): 224–234. doi:10.1093/ije/dyt259. PMC 3937980. PMID 24425828.
Mahoney MC, Nasca PC, Burnett WS, Melius JM (April 1991). “Bone cancer incidence rates in New York State: time trends and fluoridated drinking water”. 《American Journal of Public Health》 81 (4): 475–9. doi:10.2105/AJPH.81.4.475. PMC 1405037. PMID 2003628.
Kim FM, Hayes C, Williams PL, Whitford GM, Joshipura KJ, Hoover RN, Douglass CW, National Osteosarcoma Etiology Group (October 2011). “An assessment of bone fluoride and osteosarcoma”. 《Journal of Dental Research》 90 (10): 1171–6. doi:10.1177/0022034511418828. PMC 3173011. PMID 21799046.
Gelberg KH, Fitzgerald EF, Hwang SA, Dubrow R (December 1995). “Fluoride exposure and childhood osteosarcoma: a case-control study”. 《American Journal of Public Health》 85 (12): 1678–83. doi:10.2105/AJPH.85.12.1678. PMC 1615731. PMID 7503344.
Papalas JA, Balmer NN, Wallace C, Sangüeza OP (June 2009). “Ossifying dermatofibroma with osteoclast-like giant cells: report of a case and literature review”. 《Am J Dermatopathol》 31 (4): 379–83. doi:10.1097/DAD.0b013e3181966747. PMID 19461244.
Kundu ZS (May 2014). “Classification, imaging, biopsy and staging of osteosarcoma”. 《Indian Journal of Orthopaedics》 48 (3): 238–46. doi:10.4103/0019-5413.132491. PMC 4052020. PMID 24932027.
Ottaviani G, Jaffe N (2009). 〈The Epidemiology of Osteosarcoma〉. 《Pediatric and Adolescent Osteosarcoma》. Cancer Treatment and Research 152. New York: Springer. 3–13쪽. doi:10.1007/978-1-4419-0284-9_1. ISBN 978-1-4419-0283-2. PMID 20213383.
Wilkins RM, Cullen JW, Odom L, Jamroz BA, Cullen PM, Fink K, Peck SD, Stevens SL, Kelly CM, Camozzi AB (June 2003). “Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity”. 《Annals of Surgical Oncology》 10 (5): 498–507. doi:10.1245/ASO.2003.03.061. PMID 12794015. S2CID 32721347.
Sharma, Ankush; Cinti, Caterina; Capobianco, Enrico (2017). “Multitype Network-Guided Target Controllability in Phenotypically Characterized Osteosarcoma: Role of Tumor Microenvironment” (영어). 《Frontiers in Immunology》 8: 918. doi:10.3389/fimmu.2017.00918. ISSN 1664-3224. PMC 5536125. PMID 28824643.
Bech-Nielsen; S.; Haskins; M. E. 외 (1978). “Frequency of osteosarcoma among first-degree relatives of St. Bernard dogs”. 《J Natl Cancer Inst》 60 (2): 349–53. doi:10.1093/jnci/60.2.349. PMID 271748.
Ru, B.; Terracini, G. 외 (1998). “Host related risk factors for canine osteosarcoma”. 《Vet J》 156 (1): 31–9. doi:10.1016/S1090-0233(98)80059-2. PMID 9691849.
Ranen E, Lavy E, Aizenberg I, Perl S, Harrus S (2004). “Spirocercosis-associated esophageal sarcomas in dogs. A retrospective study of 17 cases (1997-2003)”. 《Veterinary Parasitology》 119 (2–3): 209–221. doi:10.1016/j.vetpar.2003.10.023. PMID 14746980.
Loukopoulos P, Thornton JR, Robinson WF (May 2003). “Clinical and pathologic relevance of p53 index in canine osseous tumors”. 《Veterinary Pathology》 40 (3): 237–48. doi:10.1354/vp.40-3-237. PMID 12724563.
Psychas, V; Loukopoulos, P; Polizopoulou, ZS; Sofianidis, G (March 2009). “Multilobular tumour of the caudal cranium causing severe cerebral and cerebellar compression in a dog.”. 《Journal of Veterinary Science》 10 (1): 81–3. doi:10.4142/jvs.2009.10.1.81. PMC 2801101. PMID 19255529.
Tomlin JL, Sturgeon C, Pead MJ, Muir P (2000년 7월 29일). “Use of the bisphosphonate drug alendronate for palliative management of osteosarcoma in two dogs”. 《The Veterinary Record》 147 (5): 129–32. doi:10.1136/vr.147.5.129. PMID 10958534. S2CID 35757270.
Fenger, Joelle M.; London, Cheryl A.; Kisseberth, William C. (2014). “Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology”. 《ILAR Journal》 55 (1): 69–85. doi:10.1093/ilar/ilu009. ISSN 1930-6180. PMID 24936031.
Sakthikumar, Sharadha; Elvers, Ingegerd; Kim, Jaegil; Arendt, Maja L.; Thomas, Rachael; Turner-Maier, Jason; Swofford, Ross; Johnson, Jeremy; Schumacher, Steven E.; Alföldi, Jessica; Axelsson, Erik; Couto, C. Guillermo; Kisseberth, William C.; Pettersson, Mats E.; Getz, Gad (2018년 7월 1일). “SETD2 Is Recurrently Mutated in Whole-Exome Sequenced Canine Osteosarcoma”. 《Cancer Research》 78 (13): 3421–3431. doi:10.1158/0008-5472.can-17-3558. ISSN 0008-5472. PMID 29724721.

pubmed.ncbi.nlm.nih.gov

Fenger, Joelle M.; London, Cheryl A.; Kisseberth, William C. (2014). “Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology”. 《ILAR Journal》 55 (1): 69–85. doi:10.1093/ilar/ilu009. ISSN 1930-6180. PMID 24936031.

nrc.gov (Global: 5,244^th place; Korean: 5,733^rd place)

“Sr-90 is known to increase the risk of bone cancer and leukemia in animals, and is presumed to do so in people”.

nrv.gov.au (Global: low place; Korean: low place)

"Fluoride", Australian government national health and medical research council.

osteosarcomasupport.org (Global: low place; Korean: low place)

“osteosarcomasupport.org” (PDF). osteosarcomasupport.org. 2012년 11월 13일에 확인함.

sarcomahelp.org (Global: low place; Korean: low place)

Buecker PJ, Gebhardt M, Weber K (2005). “Osteosarcoma”. 《ESUN》. 2009년 4월 21일에 원본 문서에서 보존된 문서. 2009년 4월 15일에 확인함.
Koshkina, NV; Corey, S (2008). “Novel Targets to Treat Osteosarcoma Lung Metastases”. 《ESUN》. 2009년 4월 24일에 원본 문서에서 보존된 문서. 2009년 4월 14일에 확인함.

semanticscholar.org (Global: 11^th place; Korean: 310^th place)

api.semanticscholar.org

Osuna D, de Alava E (2009). “Molecular pathology of sarcomas”. 《Rev Recent Clin Trials》 4 (1): 12–26. doi:10.2174/157488709787047585. hdl:10261/61716. PMID 19149759. S2CID 15039305.
He X, Pang Z, Zhang X, Lan T, Chen H, Chen M, Yang H, Huang J, Chen Y, Zhang Z, Jing W, Peng R, Zhang H (September 2018). “Consistent Amplification of FRS2 and MDM2 in Low-grade Osteosarcoma: A Genetic Study of 22 Cases With Clinicopathologic Analysis”. 《The American Journal of Surgical Pathology》 42 (9): 1143–1155. doi:10.1097/PAS.0000000000001125. PMID 30001240. S2CID 51618887.
Wilkins RM, Cullen JW, Odom L, Jamroz BA, Cullen PM, Fink K, Peck SD, Stevens SL, Kelly CM, Camozzi AB (June 2003). “Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity”. 《Annals of Surgical Oncology》 10 (5): 498–507. doi:10.1245/ASO.2003.03.061. PMID 12794015. S2CID 32721347.
Tomlin JL, Sturgeon C, Pead MJ, Muir P (2000년 7월 29일). “Use of the bisphosphonate drug alendronate for palliative management of osteosarcoma in two dogs”. 《The Veterinary Record》 147 (5): 129–32. doi:10.1136/vr.147.5.129. PMID 10958534. S2CID 35757270.

semanticscholar.org

Osuna D, de Alava E (2009). “Molecular pathology of sarcomas”. 《Rev Recent Clin Trials》 4 (1): 12–26. doi:10.2174/157488709787047585. hdl:10261/61716. PMID 19149759. S2CID 15039305.

web.archive.org (Global: 1^st place; Korean: 1^st place)

National Health and Medical Research Council (Australia) (2007). 《A systematic review of the efficacy and safety of fluoridation》 (PDF). ISBN 978-1-86496-415-8. 2009년 10월 14일에 원본 문서 (PDF)에서 보존된 문서. 2009년 10월 13일에 확인함.
"Water Fluoridation and Cancer Risk" 보관됨 2014-11-29 - 웨이백 머신, American Cancer Society, 6 June 2013.
"Cancer myth: Fluoride and cancer" 보관됨 2014-09-14 - 웨이백 머신, Cancer Council Western Australia.
"Basic Information about Fluoride in Drinking Water" 보관됨 2014-12-04 - 웨이백 머신, United States Environmental Protection Agency.
Luke's Story: Surviving Osteosarcoma 보관됨 2014-05-18 - 웨이백 머신, Children's Cancer Research Fund. Accessed 2016-11-07.
Buecker PJ, Gebhardt M, Weber K (2005). “Osteosarcoma”. 《ESUN》. 2009년 4월 21일에 원본 문서에서 보존된 문서. 2009년 4월 15일에 확인함.
Koshkina, NV; Corey, S (2008). “Novel Targets to Treat Osteosarcoma Lung Metastases”. 《ESUN》. 2009년 4월 24일에 원본 문서에서 보존된 문서. 2009년 4월 14일에 확인함.
Withrow, S.J. (2003). “Limb Sparing Trials and Canine Osteosarcoma”. 《Genes, Dogs and Cancer: 3rd Annual Canine Cancer Conference, 2003》. 2005년 3월 15일에 원본 문서에서 보존된 문서. 2006년 6월 16일에 확인함.

worldcat.org (Global: 5^th place; Korean: 11^th place)

Sharma, Ankush; Cinti, Caterina; Capobianco, Enrico (2017). “Multitype Network-Guided Target Controllability in Phenotypically Characterized Osteosarcoma: Role of Tumor Microenvironment” (영어). 《Frontiers in Immunology》 8: 918. doi:10.3389/fimmu.2017.00918. ISSN 1664-3224. PMC 5536125. PMID 28824643.
Sharma, Ankush; Capobianco, Enrico (2017). “Immuno-Oncology Integrative Networks: Elucidating the Influences of Osteosarcoma Phenotypes” (영어). 《Cancer Informatics》 16: 117693511772169. doi:10.1177/1176935117721691. ISSN 1176-9351. PMC 5533255. PMID 28804242.
Sharma, Ankush; Cinti, Caterina; Capobianco, Enrico (2017). “Multitype Network-Guided Target Controllability in Phenotypically Characterized Osteosarcoma: Role of Tumor Microenvironment” (영어). 《Frontiers in Immunology》 8: 918. doi:10.3389/fimmu.2017.00918. ISSN 1664-3224. PMC 5536125. PMID 28824643.
Fenger, Joelle M.; London, Cheryl A.; Kisseberth, William C. (2014). “Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology”. 《ILAR Journal》 55 (1): 69–85. doi:10.1093/ilar/ilu009. ISSN 1930-6180. PMID 24936031.
Sakthikumar, Sharadha; Elvers, Ingegerd; Kim, Jaegil; Arendt, Maja L.; Thomas, Rachael; Turner-Maier, Jason; Swofford, Ross; Johnson, Jeremy; Schumacher, Steven E.; Alföldi, Jessica; Axelsson, Erik; Couto, C. Guillermo; Kisseberth, William C.; Pettersson, Mats E.; Getz, Gad (2018년 7월 1일). “SETD2 Is Recurrently Mutated in Whole-Exome Sequenced Canine Osteosarcoma”. 《Cancer Research》 78 (13): 3421–3431. doi:10.1158/0008-5472.can-17-3558. ISSN 0008-5472. PMID 29724721.

골육종 (Korean Wikipedia)

archive.org (Global: 6th place; Korean: 18th place)

cancer.gov (Global: 1,684th place; Korean: 647th place)

cancer.org (Global: 3,680th place; Korean: 3,568th place)

cancerwa.asn.au (Global: low place; Korean: low place)

cdc.gov (Global: 218th place; Korean: 52nd place)

childrenscancer.org (Global: low place; Korean: low place)

doi.org (Global: 2nd place; Korean: 3rd place)

dx.doi.org

doi.org

epa.gov (Global: 882nd place; Korean: 710th place)

water.epa.gov

grandroundsjournal.com (Global: low place; Korean: low place)

handle.net (Global: 102nd place; Korean: 307th place)

hdl.handle.net

ivis.org (Global: low place; Korean: low place)

lecturio.com (Global: 5,619th place; Korean: 9,269th place)

nhmrc.gov.au (Global: low place; Korean: 8,116th place)

nih.gov (Global: 4th place; Korean: 4th place)

ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov

nrc.gov (Global: 5,244th place; Korean: 5,733rd place)

nrv.gov.au (Global: low place; Korean: low place)

osteosarcomasupport.org (Global: low place; Korean: low place)

sarcomahelp.org (Global: low place; Korean: low place)

semanticscholar.org (Global: 11th place; Korean: 310th place)

api.semanticscholar.org

semanticscholar.org

web.archive.org (Global: 1st place; Korean: 1st place)

worldcat.org (Global: 5th place; Korean: 11th place)

archive.org (Global: 6^th place; Korean: 18^th place)

cancer.gov (Global: 1,684^th place; Korean: 647^th place)

cancer.org (Global: 3,680^th place; Korean: 3,568^th place)

cdc.gov (Global: 218^th place; Korean: 52^nd place)

doi.org (Global: 2^nd place; Korean: 3^rd place)

epa.gov (Global: 882^nd place; Korean: 710^th place)

handle.net (Global: 102^nd place; Korean: 307^th place)

lecturio.com (Global: 5,619^th place; Korean: 9,269^th place)

nhmrc.gov.au (Global: low place; Korean: 8,116^th place)

nih.gov (Global: 4^th place; Korean: 4^th place)

nrc.gov (Global: 5,244^th place; Korean: 5,733^rd place)

semanticscholar.org (Global: 11^th place; Korean: 310^th place)

web.archive.org (Global: 1^st place; Korean: 1^st place)

worldcat.org (Global: 5^th place; Korean: 11^th place)